Fidelity Investments’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $395M | Sell |
12,151,050
-361,184
| -3% | -$11.7M | 0.02% | 579 |
|
|
2025
Q1 | $472M | Sell |
12,512,234
-579,414
| -4% | -$21.9M | 0.03% | 475 |
|
|
2024
Q4 | $1.07B | Sell |
13,091,648
-2,709,019
| -17% | -$222M | 0.06% | 247 |
|
|
2024
Q3 | $1.81B | Sell |
15,800,667
-366,673
| -2% | -$41.9M | 0.11% | 149 |
|
|
2024
Q2 | $1.22B | Sell |
16,167,340
-93,819
| -0.6% | -$7.08M | 0.08% | 203 |
|
|
2024
Q1 | $1.11B | Buy |
16,261,159
+2,047,794
| +14% | +$140M | 0.07% | 232 |
|
|
2023
Q4 | $893M | Buy |
14,213,365
+136,328
| +1% | +$8.56M | 0.07% | 255 |
|
|
2023
Q3 | $718M | Buy |
14,077,037
+20,801
| +0.1% | +$1.06M | 0.06% | 285 |
|
|
2023
Q2 | $702M | Buy |
14,056,236
+2,247,671
| +19% | +$112M | 0.06% | 312 |
|
|
2023
Q1 | $443M | Buy |
11,808,565
+1,639,283
| +16% | +$61.4M | 0.04% | 449 |
|
|
2022
Q4 | $488M | Buy |
10,169,282
+1,272,085
| +14% | +$61M | 0.05% | 401 |
|
|
2022
Q3 | $214M | Buy |
8,897,197
+383,791
| +5% | +$9.21M | 0.02% | 635 |
|
|
2022
Q2 | $185M | Buy |
8,513,406
+136,464
| +2% | +$2.97M | 0.02% | 720 |
|
|
2022
Q1 | $202M | Buy |
8,376,942
+502,592
| +6% | +$12.1M | 0.02% | 769 |
|
|
2021
Q4 | $187M | Buy |
7,874,350
+45,965
| +0.6% | +$1.09M | 0.01% | 828 |
|
|
2021
Q3 | $199M | Buy |
7,828,385
+121,576
| +2% | +$3.08M | 0.02% | 812 |
|
|
2021
Q2 | $173M | Buy |
7,706,809
+7,666
| +0.1% | +$173K | 0.01% | 877 |
|
|
2021
Q1 | $152M | Buy |
7,699,143
+56,738
| +0.7% | +$1.12M | 0.01% | 903 |
|
|
2020
Q4 | $203M | Buy |
7,642,405
+1,266,642
| +20% | +$33.7M | 0.02% | 742 |
|
|
2020
Q3 | $315M | Buy |
6,375,763
+1,669,004
| +35% | +$82.4M | 0.03% | 455 |
|
|
2020
Q2 | $149M | Buy |
+4,706,759
| New | +$149M | 0.02% | 719 |
|